Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT07061535 · RECRUITING

Trial details

NCT number: NCT07061535
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive-stage Small Cell Lung Cancer (ES-SCLC)Extensive Stage Lung Small Cell Cancer Extensive-Stage Small-Cell Lung Cancer Extensive Disease Small Cell Lung Cancer

Start date: 2025-07-30
Primary completion: 2027-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.